QQ客服 官方微博 反馈留言

浏览/检索结果: 共25条，第1-10条 帮助 限定条件 发表日期：2020    专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Discovery and Optimization of Non-bile Acid FXR Agonists as Preclinical Candidates for the Treatment of Nonalcoholic Steatohepatitis 期刊论文 JOURNAL OF MEDICINAL CHEMISTRY, 2020, 卷号: 63, 期号: 21, 页码: 12748-12772 作者:  Li, Junyou;  Liu, Mengqi;  Li, Yazhou;  Sun, Dan-dan;  Shu, Zhihao 收藏  |  浏览/下载：24/0  |  提交时间：2021/05/24 Engineering Prodrug Nanomedicine for Cancer Immunotherapy 期刊论文 ADVANCED SCIENCE, 2020, 页码: 33 作者:  Yang, Bin;  Gao, Jing;  Pei, Qing;  Xu, Huixiong;  Yu, Haijun 收藏  |  浏览/下载：24/0  |  提交时间：2020/12/21 cancer immunotherapy  combination immunotherapy  nanomedicine  prodrugs  stimuli‐  responsive   Metabolic modulation via mTOR pathway and anti-angiogenesis remodels tumor microenvironment using PD-L1-targeting codelivery 期刊论文 BIOMATERIALS, 2020, 卷号: 255, 页码: 12 作者:  Chen, Binfan;  Gao, Ang;  Tu, Bin;  Wang, Yonghui;  Yu, Xiaolu 收藏  |  浏览/下载：31/0  |  提交时间：2020/12/24 Tumor-associated macrophage  Glycolysis  mTOR  Angiogenesis  Tumor immune microenvironment  Liposome   SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 7 作者:  Xia, Zong-jun;  Ji, Yin-chun;  Sun, De-qiao;  Peng, Xia;  Gao, Ying-lei 收藏  |  浏览/下载：82/0  |  提交时间：2020/12/21 ROS1 kinase  ROS1 inhibitor  SAF-189s  lorlatinib  crizotinib resistance  G2032R mutant  NSCLC   Comparative Transcriptomic and Proteomic Analyses Prove that IFN-lambda 1 is a More Potent Inducer of ISGs than IFN-alpha against Porcine Epidemic Diarrhea Virus in Porcine Intestinal Epithelial Cells 期刊论文 JOURNAL OF PROTEOME RESEARCH, 2020, 卷号: 19, 期号: 9, 页码: 3697-3707 作者:  Zhao, Mingzhi;  Li, Liang;  Zhai, Linhui;  Yue, Qi;  Liu, Hongyu 收藏  |  浏览/下载：67/0  |  提交时间：2020/12/21 intestinal epithelial cell  IFN-lambda 1  IFN-alpha  anti-PEDV  transcriptomics  proteomics   Activation of unfolded protein response overcomes Ibrutinib resistance in diffuse large B-cell lymphoma 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 10 作者:  Zhang, Xiao-tuan;  Hu, Xiao-bei;  Wang, Han-lin;  Kan, Wei-juan;  Xu, Lei 收藏  |  浏览/下载：55/0  |  提交时间：2020/12/24 DLBCL  BTK inhibitor  ibrutinib resistance  UPR  TUDCA  2-DG   Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 11 作者:  Su, Hai-xia;  Yao, Sheng;  Zhao, Wen-feng;  Li, Min-jun;  Liu, Jia 收藏  |  浏览/下载：120/0  |  提交时间：2020/12/24 SARS-CoV-2  3CL protease  traditional Chinese medicines  Shuanghuanglian oral liquid  baicalin  baicalein   Bioreducible poly (beta-amino esters)/shRNA complex nanoparticles for efficient RNA delivery (vol 151, pg 35, 2011) 期刊论文 JOURNAL OF CONTROLLED RELEASE, 2020, 卷号: 323, 页码: 321-322 作者:  Yin, Qi;  Gao, Yu;  Zhang, Zhiwen;  Zhang, Pengcheng;  Li, Yaping 收藏  |  浏览/下载：2/0  |  提交时间：2020/12/24 Identification of Highly Selective Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Inhibitors by a Covalent Fragment-Based Approach 期刊论文 JOURNAL OF MEDICINAL CHEMISTRY, 2020, 卷号: 63, 期号: 13, 页码: 7052-7065 作者:  Huang, Fubao;  Hu, Hangchen;  Wang, Kai;  Peng, Chengyuan;  Xu, Wenwei 收藏  |  浏览/下载：46/0  |  提交时间：2020/12/24 'TRAIL-based gene delivery and therapeutic strategies' and 'Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy' (vol 59, pg 631, 2020) 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 1 作者:  Gao, Ang;  Hu, Xian-li;  Saeed, Madiha;  Chen, Bin-fan;  Li, Ya-ping 收藏  |  浏览/下载：17/0  |  提交时间：2020/12/24